Financials InterCure Ltd.

Equities

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE 07:24:08 2024-04-25 am EDT 5-day change 1st Jan Change
999.9 ILa +0.77% Intraday chart for InterCure Ltd. +5.81% +115.91%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 28.9 417.5 404.1 440.5 932.3 550.5
Enterprise Value (EV) 2 29.05 426.6 393.6 407.6 844.6 572.9
P/E ratio -18.3 x -31.6 x -124 x -11.2 x 207 x 12.2 x
Yield - - - - - -
Capitalization / Revenue - - 45,271,664 x 6,773,655 x 4,243,845 x 1,416,365 x
EV / Revenue - - 44,099,358 x 6,268,065 x 3,844,919 x 1,473,908 x
EV / EBITDA -92.5 x -42.1 x -4.96 x 286 x 23.8 x 11.9 x
EV / FCF -52.9 x 161 x -18.4 x -33 x 116 x -12.3 x
FCF Yield -1.89% 0.62% -5.44% -3.03% 0.86% -8.16%
Price to Book 4.86 x 21.2 x 1.58 x 1.6 x 2.09 x 1.1 x
Nbr of stocks (in thousands) 17,558 18,548 24,382 26,942 44,994 45,573
Reference price 3 1.646 22.51 16.57 16.35 20.72 12.08
Announcement Date 3/26/18 4/1/19 4/30/20 3/31/21 4/5/22 3/31/23
1ILS in Million2USD in Million3ILS
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - 8.926 65.04 219.7 388.7
EBITDA 1 -0.314 -10.12 -79.4 1.425 35.53 48.34
EBIT 1 -0.315 -10.13 -79.98 -1.205 30.41 40.85
Operating Margin - - -896.06% -1.85% 13.84% 10.51%
Earnings before Tax (EBT) 1 -1.513 -12.8 -3.669 -38.31 18.74 43.84
Net income 1 -1.513 -12.8 -2.996 -37.23 4.692 44.82
Net margin - - -33.56% -57.25% 2.14% 11.53%
EPS 2 -0.0902 -0.7125 -0.1335 -1.466 0.1000 0.9882
Free Cash Flow 1 -0.5489 2.649 -21.4 -12.36 7.275 -46.73
FCF margin - - -239.8% -19% 3.31% -12.02%
FCF Conversion (EBITDA) - - - - 20.48% -
FCF Conversion (Net income) - - - - 155.04% -
Dividend per Share - - - - - -
Announcement Date 3/26/18 4/1/19 4/30/20 3/31/21 4/5/22 3/31/23
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 10.06 14.02 19.89 26.39 25.71 29.28 29.5 29.42 28.99 26.94
EBITDA 1 - - - 7.197 6.278 6.796 5.764 5.161 - 2.988
EBIT 1 1.709 2.541 2.308 2.831 4.924 4.835 4.12 2.271 1.841 1.321
Operating Margin 16.99% 18.13% 11.6% 10.73% 19.15% 16.51% 13.96% 7.72% 6.35% 4.9%
Earnings before Tax (EBT) 1 1.529 2.627 0.6695 0.7974 5.72 6.475 3.504 -2.43 0.4844 0.106
Net income 1 0.7951 1.919 -0.53 -0.9567 3.942 4.689 2.128 2.382 0.0584 1.284
Net margin 7.91% 13.69% -2.66% -3.63% 15.33% 16.01% 7.21% 8.1% 0.2% 4.77%
EPS - - - - - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 5/17/21 8/16/21 11/15/21 4/4/22 5/16/22 8/15/22 11/15/22 3/31/23 5/15/23 8/31/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 0.14 9.12 - - - 22.4
Net Cash position 1 - - 10.5 32.9 87.6 -
Leverage (Debt/EBITDA) -0.4522 x -0.9003 x - - - 0.4627 x
Free Cash Flow 1 -0.55 2.65 -21.4 -12.4 7.27 -46.7
ROE (net income / shareholders' equity) -24.8% -61.9% -2.17% -13.1% 1.94% 8.83%
ROA (Net income/ Total Assets) -2.79% -20.7% -31.4% -0.25% 3.75% 3.09%
Assets 1 54.18 61.7 9.534 15,043 125 1,452
Book Value Per Share 2 0.3400 1.060 10.50 10.20 9.930 11.00
Cash Flow per Share 2 0.0300 0.1800 1.120 1.410 4.350 5.100
Capex - 0.09 28.1 20.8 14 19.7
Capex / Sales - - 315.3% 32.05% 6.39% 5.08%
Announcement Date 3/26/18 4/1/19 4/30/20 3/31/21 4/5/22 3/31/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. INCR Stock
  4. Financials InterCure Ltd.